scispace - formally typeset
J

Jianling Li

Researcher at Wenzhou Medical College

Publications -  8
Citations -  422

Jianling Li is an academic researcher from Wenzhou Medical College. The author has contributed to research in topics: Internal medicine & Chemistry. The author has an hindex of 4, co-authored 5 publications receiving 365 citations.

Papers
More filters
Journal ArticleDOI

Evaluation and Discovery of Novel Synthetic Chalcone Derivatives as Anti-Inflammatory Agents

TL;DR: QSAR study revealed that the presence of electron-withdrawing groups in B-ring and electron-donating groups in A-ring of chalcones was important for inhibition of LPS-induced IL-6 expression, and showed a series of anti-inflammatory chalcone derivatives with potential therapeutic effects in inflammatory diseases.
Journal ArticleDOI

Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats

TL;DR: It is hypothesized that C66 affects high glucose (HG)‐induced inflammation profiles in vitro and in vivo and then prevents renal injury in diabetic rats via its anti‐inflammatory actions.
Journal ArticleDOI

Synthesis and anti-inflammatory evaluation of novel mono-carbonyl analogues of curcumin in LPS-stimulated RAW 264.7 macrophages.

TL;DR: Quantitative structure-activity relationship was conducted, indicating that electron-withdrawing groups in benzene ring are favourable to anti-inflammatory activities of B-class compounds, and compounds AN1 and B82 demonstrated anti- inflammatory abilities in a dose-dependent manner, raising the possibility that these compounds might serve as potential agents for the treatment of inflammatory diseases.
Journal ArticleDOI

A Novel Compound C12 Inhibits Inflammatory Cytokine Production and Protects from Inflammatory Injury In Vivo

TL;DR: C12 suppressed proinflammatory cytokine production in plasma and liver, attenuated lung histopathology, and significantly reduced mortality in endotoxemic mice, suggesting that this agent may be useful in the treatment of inflammatory diseases.
Journal ArticleDOI

LXRs/ABCA1 activation contribute to the anti-inflammatory role of phytosterols on LPS-induced acute lung injury

TL;DR: In this paper , the role of phytosterols was verified in LPS-stimulated RAW264.7 cells and the protective effect was weakened by administration of LXR antagonist GSK2033.